← All trials
NCT05054894
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 19, 2021
- Primary completion
- Apr 30, 2025
- Completion date
- May 31, 2025
- First posted
- Sep 23, 2021
- Last posted
- Sep 23, 2021
- Enrollment
- 100
- Arms / groups
- — / —
- Source
- AACT · ingestion pipeline
Sponsors
- Neurological Associates of West Los AngelesLead sponsor
- Neurological Associates The Interventional GroupOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.